PF-06647020

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06647020, covering 2020-12-17 to 2020-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors [Phase 1]